Oxford Nanopore Technologies (ONT) Share Price, News & Analysis

Company Overview

Oxford Nanopore Technologies' goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer. Oxford Nanopore's technology also has the potential to provide broad, high impact, rapid insights in a number of areas including healthcare, food and agriculture.

Key Stats

• Today's Range: 152.90 to 158.60
• 50-Day Range: 107.70 to 183
• 52-Week Range: 95.61 to 191.40
• Volume: 64.58 million shs
• Average Volume: 10.57 million shs
• Market Capitalization: £1.54 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: GBX 198.60
• Consensus Rating: Moderate Buy

Oxford Nanopore Technologies Stock Analysis - MarketRank™

Oxford Nanopore Technologies scored higher than 73% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Oxford Nanopore Technologies has received a consensus rating of Moderate Buy. The company's average rating score is 2.83, and is based on no strong buy ratings, 5 buy ratings, 1 hold rating, and no sell ratings.

Upside Potential

Oxford Nanopore Technologies has a consensus price target of GBX 198.60, representing about 26.1% upside from its current price of GBX 157.54.

Amount of Analyst Coverage

Oxford Nanopore Technologies has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Oxford Nanopore Technologies is -12.60, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Oxford Nanopore Technologies is -12.60, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Oxford Nanopore Technologies has a P/B Ratio of 2.35. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for ONT.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Oxford Nanopore Technologies does not currently pay a dividend.

Dividend Growth

Oxford Nanopore Technologies does not have a long track record of dividend growth.

News and Social Media

• Score: 3.2 / 5
• News Sentiment: 1.13

News Sentiment

Oxford Nanopore Technologies has a news sentiment score of 1.13. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.85 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 7 news articles for Oxford Nanopore Technologies this week, compared to 1 article on an average week.

Company Ownership

• Score: 3.2 / 5
• Insider Trading: Acquiring Shares

Cluster Insider Buying

2 insiders have purchased shares of Oxford Nanopore Technologies in the last three months. Multiple insiders buying is a strong bullish signal.

Net Insider Buying

Over the last three months, insiders have purchased a net £25,726.80 in company stock, which represents 0.0017% of the company's market cap.

Insider Buying vs. Insider Selling

In the past three months, Oxford Nanopore Technologies insiders have bought more of their company's stock than they have sold. Specifically, they have bought £25,726.80 in company stock and sold GBX 0 in company stock.

Percentage Held by Insiders

2.54% of the stock of Oxford Nanopore Technologies is held by insiders.

Percentage Held by Institutions

18.91% of the stock of Oxford Nanopore Technologies is held by institutions.

Company Calendar

• Last Earnings: 8/19/2026
• Today: 9/15/2026
• Morgan Stanley 24th Annual Global Healthcare Conference: 9/15/2026
• RBC Capital Markets Pharma Services & Life Science Tools Virtual Conference: 9/22/2026

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Healthcare
• Industry: Biotechnology
• Sub-Industry: Biotechnology
• Current Symbol: LON:ONT
• CIK: N/A
• Web: nanoporetech.com
• Phone: 44 84 5034 7900
• Fax: N/A
• Employees: 1,314
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Oxford Nanopore Technologies: GBX 198.60
• High Price Target: GBX 225
• Low Price Target: GBX 153
• Potential Upside/Downside: +26.1%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.83
• Research Coverage: 6 Analysts

Profitability

• EPS (Trailing Twelve Months): GBX (12.50)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -£175.21 million
• Net Margins: -54.66%
• Pretax Margin: N/A
• Return on Equity: -35.45%
• Return on Assets: -14.42%

Debt

• Debt-to-Equity Ratio: 9.86
• Current Ratio: 3.52
• Quick Ratio: 6.01

Sales & Book Value

• Annual Sales: £235 million
• Price / Sales: 6.55
• Cash Flow: GBX 38.99 per share
• Price / Cash Flow: 4.04
• Book Value: GBX 67.15 per share
• Price / Book: 2.35

Miscellaneous

• Outstanding Shares: 977,505,000
• Free Float: N/A
• Market Cap: £1.54 billion
• Optionable: Not Optionable
• Beta: 0.96